Information  X 
Enter a valid email address
  Print      Mail a friend       More announcements

Wednesday 04 December, 2019

BlackRock Group

Form 8.3 - AbbVie Inc.

RNS Number : 6876V
BlackRock Group
04 December 2019
 

Ap19

 

 

FORM 8.3

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

 

1.       KEY INFORMATION

 

Name of person dealing (Note 1)

BlackRock, Inc.

Company dealt in

AbbVie Inc.

Class of relevant security to which the dealings being disclosed relate (Note 2)

US$0.01 common stock

Date of dealing

03 December 2019

 

2.         INTERESTS AND SHORT POSITIONS

 

(a)        Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

 

Long

Short

(1) Relevant securities

90,601,787 (6.12%)

118,632 (0.00%)

(2) Derivatives (other than options)

1,288,814 (0.08%)

3,571,707 (0.24%)

(3) Options and agreements to purchase/sell

0 (0.00%)

105,900 (0.00%)

Total

91,890,601 (6.21%)

3,796,239 (0.25%)

             

 

(b)        Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

 

 

 

(2) Derivatives (other than options)

 

 

 

(3) Options and agreements to purchase/sell

 

 

Total

 

 

             

 

Ap20

 

 

1.       DEALINGS (Note 4)

 

(a)      Purchases and sales

 

 

 

Purchase/sale

 

Number of relevant securities

 

Price per unit (Note 5)

Purchase

7,263

USD 85.8704

Purchase

2,436

USD 85.9500

Purchase

6,133

USD 85.9613

Purchase

12,421

USD 85.9654

Purchase

1,334

USD 86.0500

Sale

589

USD 85.8130

Sale

70

USD 85.8932

Sale

695

USD 85.9346

Sale

32,703

USD 85.9500

Sale

1,334

USD 86.0500

   

Please note: there was also a Transfer In of 66,191 Shares

 

 

(b)      Derivatives transactions (other than options transactions)

 

Product name,

e.g. CFD

Nature of transaction

(Note 6)

Number of relevant securities

(Note 7)

Price per unit

(Note 5)

CFD

Increasing Long

451

USD 85.9578

CFD

Reducing Long

40

USD 85.9070

CFD

Reducing Long

1,627

USD 85.9137

CFD

Reducing Long

1,357

USD 85.9226

CFD

Reducing Long

180

USD 85.9500

CFD

Increasing Short

49,784

USD 85.9364

   

(c)      Options transactions in respect of existing relevant securities

 

 

(i)       Writing, selling, purchasing or varying

 

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

 

 

 

 

 

 

 

 

(ii)      Exercising

 

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 5)

 

 

 

 

(d)      Other dealings (including transactions in respect of new securities) (Note 4)

 

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

Stock on Loan

2,665,588

N/A

Return of Stock on Loan

913,200

N/A

   

 

Ap21

 

2.       OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

 

Full details of any agreement, arrangement or understanding between the person disclosing and any 

other person relating to the voting rights of any relevant securities under any option referred to on this 

form or relating to the voting rights or future acquisition or disposal of any relevant securities to which 

any derivative referred to on this form is referenced. If none, this should be stated.

 

 

 

None

 

 

 

Is a Supplemental Form 8 attached? (Note 9)                                    YES

 

Date of disclosure

04 December 2019

Contact name

Jana Blumenstein

Telephone number

+44 20 7743 3650

If a connected EFM, name of offeree/offeror with which connected

 

If a connected EFM, state nature of connection (Note 10)

 

 

 

 

Ap23

 

 

SUPPLEMENTAL FORM 8

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DETAILS OF OPEN POSITIONS

 

(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)

 

OPEN POSITIONS (Note 1)

 

Product name,

e.g. call option

Written, or purchased

Number of relevant securities to which the option or derivative relates

Exercise price (Note 2)

Type, e.g. American, European etc.

Expiry date

Call Option

Written

18,400

USD 80.0000

American

20/12/2019

Call Option

Written

24,000

USD 89.5000

European

09/01/2020

Call Option

Written

24,000

USD 87.5000

American

17/01/2020

Call Option

Written

39,500

USD 90.0000

American

21/02/2020

 

Notes

 

1.         Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.

 

2.         For all prices and other monetary amounts, the currency must be stated.

 

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
ISEKMMGZZDDGLZM

a d v e r t i s e m e n t